Once produced, APIs are typically combined with excipients to create a final pharmaceutical product. Excipients are inactive substances that serve as the vehicle for the API, aiding in drug formulation, stability, and delivery. The combination of API and excipients forms the final dosage form, such as tablets, capsules, or injectables.
In conclusion, the COVID-19 pandemic has had a far-reaching impact on public health and society. While it has exposed vulnerabilities within health systems and exacerbated social inequalities, it has also paved the way for scientific innovation and highlighted the need for global collaboration. As countries continue to navigate the aftermath of the pandemic, the lessons learned will shape future health policies and prepare us better for potential health emergencies. It is essential to foster resilience in our systems and communities to withstand future challenges, ensuring that everyone has access to the care and support they need.